Biocides Product Committee backs approval of two active substances used in disinfectants
The Biocide Product Committee (BPC) has recommended the approval ADBAC/BKC and DDAC for use in two disinfectant product types:
Type 3 (animal hygiene products such as disinfectants and oral or corporal hygiene products ) and
Type 4 (equipment, containers and surfaces needed in the production, transport, storage or consumption of food or feed for people and animals).
The European Commission, together with EU Member States, will take the final decision on the approval of the active substances. However, companies with biocidal products containing these active substance/product type combinations should start preparing to apply for Product Authorisation.
Yordas advises companies to start planning and budgeting now to apply for Product Authorisation to ensure continuity on the EU market.
Do you need help with complying with the new GB-BPR?
Our regulatory experts can help your business reach compliance and avoid penalties.
You can read more about our Biocidal services here.
A “same biocidal product” is a regulatory concept introduced under EU BPR through an amendment regulation (Commission Implementing Regulation (EU) 2016/1802). Under this process, an applicant may submit their own biocidal product authorisation application for a product which is authorised or under evaluation for authorisation. Learn more here.
The regulation of sanitizers and disinfectants in Canada involves multiple agencies working together to ensure products are safe. This article delves into the intricacies of this regulatory landscape.
The European Commission's recent approval of Alkyl (C12-16) Dimethylbenzyl Ammonium Chloride (ADBAC/BKC) as an active substance for use in biocidal products of product type (PT) 2 marks a significant milestone in the regulatory landscape. Learn more about this update here.
The EU Commission has recently commissioned a public consultation regarding an extension to the Biocidal Active Substance Review Programme (RP). Under the RP, any substance which was placed on the EU market as an active substance in biocidal products before 14th May 2000 must undergo an evaluation. Click to learn more.
If you're looking to market biocidal products in different regions, scoping assessment reports are a great way to evaluate your company's obligations and determine the best compliance strategy. Click for more insight into scoping assessments.
Companies in the EU must comply with the new regulatory framework for veterinary medicines. The new regulation intends to harmonise the internal EU market, ease the administrative burden, increase availability and ensure the highest level of safety of these products.
Recently, the European Chemicals Agency (ECHA) published several active substance approval regulations. Find out if these changes impact your products and how Yordas can help you comply with the regulations.
Learn how the new legislation aims to provide more consistency and allow for greater alignment between Canadian and other global regulations of similar substances, leading to shorter registration times.
As society’s risk tolerance changes, there is a greater need for sound strategies and substitutions to phase out the use of hazardous substances in favour of more sustainable alternatives.
Learn how our team of scientific experts work with a trusted global network of Contract Research Organisations to offer a full range of services that can help you meet the demands of EU REACH